ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,845Medicare Part D Prescriptions Filled, Including Refills

Rank: 139 out of 783

$711K Total Retail Price of All Prescriptions

Rank: 132 out of 783

397 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 397 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

22% of this provider’s 397 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 9,953 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 518 425 S3 1 2
AMLODIPINE BESYLATE 511 432 2 5
LEVOTHYROXINE SODIUM 438 412 3 1
SIMVASTATIN 398 351 4 3
BENAZEPRIL HCL 376 345 5 85
FUROSEMIDE 240 203 6 7
GABAPENTIN 214 173 7 15
METOPROLOL TARTRATE 212 187 8 9
LOSARTAN POTASSIUM 206 189 9 18
ZOLPIDEM TARTRATE 196 159 10 23
CITALOPRAM HBR 189 160 11 19
HYDROCHLOROTHIAZIDE 180 160 12 12
OMEPRAZOLE 175 171 13 6
POTASSIUM CHLORIDE 166 142 14 16
NAMENDA 165 165 15 32
WARFARIN SODIUM 161 128 16 10
FLUTICASONE PROPIONATE 156 90 17 46
METOPROLOL SUCCINATE 150 132 18 13
NEXIUM 147 119 19 28
LISINOPRIL 139 95 20 4
DOXAZOSIN MESYLATE 133 127 21 87
METFORMIN HCL 130 115 22 8
LOVASTATIN 124 99 23 58
ATENOLOL 117 113 24 17
ESCITALOPRAM OXALATE 112 112 25 54
LOSARTAN-HYDROCHLOROTHIAZIDE 111 107 26 53
ATORVASTATIN CALCIUM 103 87 27 11
PROAIR HFA 98 79 28 56
CRESTOR 96 96 29 27
DONEPEZIL HCL 93 93 30 24
RANITIDINE HCL 92 64 31 44
GLIPIZIDE ER 92 72 31 84
SERTRALINE HCL 91 79 33 22
TAMSULOSIN HCL 91 86 33 26
DIOVAN 88 67 35 49
LANSOPRAZOLE 88 74 35 177
ALLOPURINOL 79 47 37 31
CLOPIDOGREL 77 73 38 29
TRAMADOL HCL 75 62 39 20
PREDNISONE 75 62 39 36
DILTIAZEM 24HR ER 73 73 41 122
SPIRONOLACTONE 72 60 42 57
AZITHROMYCIN 72 65 42 41
CARVEDILOL 72 69 42 21
FLUOXETINE HCL 71 60 45 45
SINGULAIR 67 61 46 90
PRAVASTATIN SODIUM 65 61 47 14
CIPROFLOXACIN HCL 64 53 48 62
KLOR-CON M10 58 45 49 137
METFORMIN HCL ER 56 51 50 64
CLONIDINE HCL 55 55 51 60
SPIRIVA 55 40 51 59
PLAVIX 54 51 53 51
ROPINIROLE HCL 53 36 54 74
ADVAIR DISKUS 53 37 54 50
AMITRIPTYLINE HCL 52 42 R 56 77
CYCLOBENZAPRINE HCL 52 34 R 56 63
KLOR-CON 10 52 47 56 102
FENOFIBRATE 51 38 59 66
MECLIZINE HCL 51 40 59 146
CYMBALTA 50 50 61 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.